Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Study to Optimize Therapy of Burkitt's Leukemia (B-ALL) and Non-Hodgkin Lymphoma

NCT01290120 is registered in ClinicalTrials.gov with Northern Italy Leukemia Group as lead sponsor.

NCT NCT01290120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Study to Optimize Therapy of Burkitt's Leukemia (B-ALL) and Non-Hodgkin Lymphoma
Lead sponsor
Northern Italy Leukemia Group
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
June 30, 2014
Enrollment
182 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

b-all, burkitt lymphoma